Table 1.
Parameter | Data Source |
---|---|
Burden (macro models) |
Mortality Data: ■ WHO Global Burden of Disease reports [[18,26] ■ Demographic and Health Surveys (DHS)[27] ■ Multiple Indicator Cluster Surveys [28] Morbidity Data: ■ DHS ■ Published literature |
Risk of Infection (micro models) | ■ Published literature ■ UNAIDS or WHO reports (for epidemic data) [29,30] ■ PSI population-based surveys (for behaviors such as sexual behavior or drug use behavior) [31] |
Efficacy/Effectiveness | ■ Published randomized controlled trials, community randomized trials ■ Child Health Epidemiology Reference Group (CHERG) reviews [32] ■ Cochrane Literature Review [33] ■ WHO Global Burden of Disease reports |
Attrition, or Wastage | ■ PSI supply chain studies (as of 2011) ■ PSI population-based surveys (as of 2011) ■ Communication with PSI programmers Note: Wastage data are rarely available in the published literature so wastage levels were assumed until 2011. |
Utilization (including adherence) |
Utilization Data: ■ PSI population-based surveys ■ USAID CYP conversion factor for family planning products [34] ■ Published literature Adherence Data: ■ Published literature ■ PSI product usage studies (e.g., pill counts in HAART program) ■ Communication with experts in the field Note that protective efficacy/effectiveness studies, such as CHERG reviews, are likely to have adherence/compliance data embedded in them already. |
Time frame | Defined as one year. For products/services with lifespans longer than one year, all years of impact are counted in the year of distribution. |
Disability Weight | Global Burden of Disease and Risk Factors [18] |
Duration of Disease or Disability | Published literature |
Age at Death due to Disease or Disability | ■ Age distribution data of age at death ■ Weighted estimates of age at death based on age group data from Global Burden of Disease and Risk Factors [18] |
Life Expectancy | WHO, 2011 (for Japanese life expectancy data) [35] |